Nearly 32,000 men die from prostate cancer in the United States every year. Without early-warning symptoms, the PSA test currently remains the best way to detect prostate cancer early. At Urology Partners our world-class prostate cancer specialists help men understand their PSA levels and risk for prostate cancer.
Call 866-367-8768Don't worry. Let the experienced urologists at Urology Partners help you navigate next steps.
CALL 866-367-8768.
Men often worry that an elevated PSA means they may have prostate cancer. Fortunately, only 25-30 percent of men with a PSA between 2.5 and 10 will be diagnosed with prostate cancer, and the majority of those men will have very early-stage cancer.
While some criticize PSA screening, it's important to know that prostate cancer deaths have declined 44 percent since it was introduced in 1991. Today, it continues to remain the best way to detect prostate cancer.
The PSA is a simple blood test that measures the amount of a specific protein—prostate-specific antigen (PSA)—in a man’s bloodstream. PSA is a protein molecule produced not only by prostate cells, but also by prostate cancer cells. PSA protein should remain in the prostate and within ejaculate where it helps liquefy semen and break down other proteins to help sperm live longer after a man ejaculates. A small number of PSA molecules can leak into the bloodstream, but when a PSA level is higher than normal, it may be a sign of something more serious happening in the prostate.
There are several situations that can lead to a falsely elevated PSA and should be considered before having blood drawn for a PSA test. Men should delay having a PSA test if they have painful urination or a urinary tract infection, engaged in sexual activity with the last 24 hours, or undergone a cystoscopy, catheter insertion or other urinary instrumentation.
Several other factors can cause an elevated PSA, including a man’s age (the prostate naturally grows over time), an enlarged prostate and inflammation of the prostate (with or without symptoms). A simple digital rectal exam (DRE) in the office should not cause any significant rise in PSA. This has been studied extensively, so don’t worry about getting a PSA after a DRE.
The PSA molecule circulates throughout the body in two forms—either bound to other proteins or unbound. The free PSA measures the unbound molecule and is often used by urologists as another helpful indicator for prostate cancer. The lower the percent of free PSA, the higher the risk of having prostate cancer. Patients with free PSA of less than 10 percent can have up to a 56 percent risk of harboring a focus of cancer in their prostates.
Prostate cancer is known as the silent killer because it rarely exhibits any early warning symptoms such as pain or blood in the urine. When prostate cancer becomes metastatic (migrates beyond the prostate and into the bones), it is incurable. Yet, when it is found early, many types of prostate cancer can be followed closely and be effectively treated.
The five-year survival rate for men with local or regional prostate cancer is 100 percent. The five-year survival rate for men diagnosed with metastatic prostate cancer at their original diagnosis is only 30 percent. Urology Partners wants men to know that we have your back on this one. Not every man needs treatment, but the ones who do should get it early before they become another cancer statistic.